Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT 50.20
-1.40 (-2.71%)
At close: May 13, 2025
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 5.39 billion as of May 13, 2025. Its market cap has decreased by -40.59% in one year.
Market Cap
5.39B
Enterprise Value
10.20B
Revenue
7.98B
Ranking
n/a
PE Ratio
12.79
Stock Price
50.20
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 5.39B, an increase of 90.15%. That is a compound annual growth rate of 28.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 5.39B | 3.29% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grameenphone | 402.39B |
| Square Pharmaceuticals PLC. | 188.99B |
| British American Tobacco Bangladesh Company | 167.08B |
| Robi Axiata PLC. | 130.42B |
| Walton Hi-Tech Industries | 125.75B |
| Bangladesh Export Import Company | 103.85B |
| BRAC Bank PLC. | 91.85B |
| Berger Paints Bangladesh | 82.38B |